Abstract: The present invention relates to new aromatic-amino functional siloxanes, which are compounds comprising one or two tail groups X2, and a linking group L of structure (2) linking each said tail group to said head group, wherein the head group X has structure (1), containing an optional organic moiety Y, wherein the attachment point of said tail group X2 through said linking group L to the head group X1, may be, at positions a, b, c, d, or e. Another aspect of this invention are compositions containing these novel aromatic amino functional siloxane. A further aspect of this invention are compositions comprised of the above novel aromatic-amino functional siloxanes, and also the composition resulting from the aging of these compositions at room temperature for about 1 day to about 4 weeks.
Abstract: The present invention relates to metal complexes and to electronic devices, especially organic electroluminescent devices, comprising these metal complexes.
Type:
Grant
Filed:
July 27, 2016
Date of Patent:
June 8, 2021
Assignee:
Merck Patent GmbH
Inventors:
Philipp Stoessel, Nils Koenen, Christian Ehrenreich
Abstract: The present invention provides 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be therapeutically useful as DHODH inhibitors, in which R1 to R3 and ‘m’ have the meanings given in the specification, and pharmaceutically acceptable salts or stereoisomer thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage in inhibiting DHODH. The present invention also provides methods for synthesizing 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives of formula (I). The present invention also provides pharmaceutical formulations comprising at least one of the DHODH inhibitor compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient.
Abstract: Compounds of the formula I in which X, Q, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.
Abstract: [Problem] To provide a composition for a black matrix which is a material suitable for manufacturing a black matrix, which is suitable for a high luminance display device structure and has high heat resistance and high light-shielding properties. [Means for Solution] The present invention uses a composition for a black matrix comprising: (I) a black colorant containing carbon black having a volume average particle diameter of 1 to 300 nm; (II) a siloxane polymer to be obtained by hydrolyzing and condensing a silane compound represented by a prescribed formula in the presence of an acidic or basic catalyst; (III) surface modified silica fine particles; (IV) a thermal base generator; and (V) a solvent.
Abstract: The present invention relates to a photosensitive resin composition suitable for forming a thick film, which comprises (A) an alkali-soluble resin, (B) at least one plasticizer selected from a group consisting of an alkali-soluble vinyl resin and an acid-dissociable group containing vinyl resin, (C) an acid generator, and (D) an organic solvent.
Abstract: The invention relates to the use of specific benzylidenemalonates, in particular in a cosmetic preparation, for protecting the skin against chemically induced stress, in particular against chemically induced stress caused by heavy metals and/or particulate matter, or for the prevention and/or prophylaxis of epidermal morphological change.
Abstract: The present invention relates to a display device, in particular a backlit display device having a visible side and a back side, which appears opaque in colour and texture on viewing of the visible side without backlighting, but, with the backlighting switched on, is sufficiently transparent that the transmission of information by the light source from the back side is possible, and to the production of a display device of this type and to the use thereof.
Abstract: The present invention relates to liquid-crystalline media comprising one or more mesogenic compounds of formula I as set forth hereinafter, wherein the one or more compounds of formula I are contained in the medium in an amount, based on the overall contents of the medium, of at least 15% by weight. The present invention further relates to a switching layer, a switching element and a window element containing the liquid-crystalline medium.
Type:
Application
Filed:
December 3, 2018
Publication date:
June 3, 2021
Applicant:
Merck Patent GmbH
Inventors:
Michael JUNGE, Andreas BEYER, Mila FISCHER, Ewa PTAK
Abstract: The invention discloses immunoglobulin fusion proteins designed to bind both CD47 and a tumor cell antigen. The immunoglobulin fusion proteins include a SIRP? moiety that binds CD47 and an antigen binding site for a tumor cell antigen.
Abstract: A connecting mechanism (1) for a cartridge-type replaceable module (2) that has at least one fluid port (2a, 2b) at each of opposite sides of the module (2) in a longitudinal direction of the module (2). The connecting mechanism (1) comprises two connector elements (3) spaced apart in the longitudinal direction of the module (2) and each provided with at least one fluid connector (3b) configured to releasably inter-engage with a complementary fluid port (2a, 2b) of the module (2) at the respective side thereof, wherein at least one of the connector elements (3) is movable to perform a translational movement in the longitudinal direction of the module (2).
Type:
Grant
Filed:
January 21, 2016
Date of Patent:
June 1, 2021
Assignee:
Merck Patent GmbH
Inventors:
Pascal Roitel, Germain Gaydier, Thierry Cassou, Christian Berducat
Abstract: A rotor device for a peristaltic pump containing a housing, a supporting shaft extending in an axial direction and being mounted in the housing, a rotor which contains a rotor-body mounted on the supporting shaft and extending in a radial direction from the supporting shaft and a plurality of rollers, mounted on the radially outer portion of the rotor-body and a driving device connected to the supporting shaft for driving the rotor, in which the peristaltic pump further contains a number of roller-markers corresponding to the number of rollers, in which the roller-markers indicate a dead zone, the roller-markers are provided directly or indirectly on the supporting shaft.
Type:
Grant
Filed:
June 25, 2015
Date of Patent:
June 1, 2021
Assignee:
Merck Patent GmbH
Inventors:
Raoul Weil, Emmanuelle Simon, Christophe Di-Palo, Vincent Schaal
Abstract: The present invention relates to metal complexes and to electronic devices, especially organic electroluminescent devices, comprising these metal complexes, especially as emitters, and in particular monometallic metal complex containing a hexadentate tripodal ligand in which three bidentate sub-ligands coordinate to a metal and the three bidentate sub-ligands, which may be the same or different, are joined via a bridge.
Type:
Grant
Filed:
January 7, 2016
Date of Patent:
June 1, 2021
Assignee:
Merck Patent GmbH
Inventors:
Philipp Stoessel, Nils Koenen, Philipp Harbach, Christian Ehrenreich
Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
Type:
Grant
Filed:
February 14, 2018
Date of Patent:
May 25, 2021
Assignee:
MERCK PATENT GMBH
Inventors:
Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.
Type:
Grant
Filed:
February 14, 2018
Date of Patent:
May 25, 2021
Assignee:
Merck Patent GmbH
Inventors:
Martin Schraub, Lars Dobelmann-Mara, Stefan Riedmueller
Abstract: The present application relates to a liquid-crystalline material comprising a sterically hindered N-oxide and a dye. The invention furthermore relates to the use of the liquid-crystalline material in an optical switching device for regulation of the passage of sunlight.
Type:
Grant
Filed:
May 16, 2017
Date of Patent:
May 25, 2021
Assignee:
MERCK PATENT GMBH
Inventors:
Michael Junge, Ursula Patwal, Ewa Dominica Ptak
Abstract: The present invention relates to a pigment mixture based on at least two components A and B, where component A is a mixture of flake-form and spherical substrates which is covered with one or more inorganic layers and/or organic layers, and component B comprises crystalline or amorphous particles selected from the group of the metal oxides, metal hydroxides, metal oxy-halides, Prussian Blue or mixtures thereof, and to the use thereof in paints, coatings, printing inks, security printing inks, plastics, ceramic materials, glasses, in cosmetic formulations, as tracer, as filler and for the preparation of pigment preparations and dry preparations.
Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterised in that it comprises one or more compounds of the formula I in a total concentration of ?40%, in which the parameters have the meanings indicated in claim 1, and to the use of the liquid-crystalline medium for electro-optical purposes, in particular in liquid-crystal light valves for lighting devices for motor vehicles, and to liquid-crystal light valves which comprise this medium and lighting devices for motor vehicles which contain such liquid-crystal light valves.